(Q48193720)

9 February 2018

title

Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity. (English)

1 reference

9 February 2018

0 references

1 reference

Przemyslaw Nowak

1

1 reference

ORCID Public Data File 2021

Joanna Oswiecimska

4

object named as

Joanna Oswiecimska

1 reference

9 February 2018

Ryszard Brus

9

object named as

Ryszard Brus

1 reference

9 February 2018

author name string

Aleksandra Bortel

2

1 reference

9 February 2018

Joanna Dabrowska

3

1 reference

9 February 2018

Marzena Drosik

5

1 reference

9 February 2018

Adam Kwiecinski

6

1 reference

9 February 2018

Józef Opara

7

1 reference

9 February 2018

Richard M Kostrzewa

8

1 reference

9 February 2018

publication date

1 February 2007

1 reference

9 February 2018

published in

Neurotoxicity Research

1 reference

9 February 2018

volume

11

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

131-144

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/bf03033391

exact match

0 references

cites work

Brain microdialysis and its application for the study of animal behaviour

1 reference

12 December 2020

Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats.

1 reference

12 December 2020

The nigrostriatal dopamine system: a neglected target for 5-HT2C receptors

1 reference

12 December 2020

Pharmacological and physicochemical properties of pre-versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study

1 reference

12 December 2020

Supersensitized D1 receptors mediate enhanced oral activity after neonatal 6-OHDA

1 reference

12 December 2020

A Treatment Algorithm for Attention Deficit Hyperactivity Disorder in Cocaine-Dependent Adults: A One-Year Private Practice Study with Long-Acting Stimulants, Fluoxetine, and Bupropion.

1 reference

12 December 2020

Local infusion of the selective 5HT-1b agonist CP-93,129 facilitates striatal dopamine release in vivo

1 reference

12 December 2020

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

1 reference

12 December 2020

Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats

1 reference

12 December 2020

Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia

1 reference

12 December 2020

Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system

1 reference

12 December 2020

Inbreeding of Wistar-Kyoto rat strain with hyperactivity but without hypertension.

1 reference

12 December 2020

Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study

1 reference

12 December 2020

Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment

1 reference

12 December 2020

Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity.

1 reference

12 December 2020

Animal models of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity.

1 reference

12 December 2020

Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.

1 reference

12 December 2020

Attention-deficit hyperactivity disorder and hyperkinetic disorder

1 reference

12 December 2020

Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum

1 reference

12 December 2020

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum

1 reference

12 December 2020

Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.

1 reference

12 December 2020

Peculiarities of L: -DOPA treatment of Parkinson's disease

1 reference

12 December 2020

Evidence for volume transmission in the dopamine denervated neostriatum of the rat after a unilateral nigral 6-OHDA microinjection. Studies with systemic D-amphetamine treatment

1 reference

12 December 2020

In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry

1 reference

12 December 2020

5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes.

1 reference

12 December 2020

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2Asites for PCP-induced locomotion in the rat

1 reference

12 December 2020

Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.

1 reference

12 December 2020

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

1 reference

12 December 2020

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

12 December 2020

Serotonin-facilitated dopamine release in vivo: pharmacological characterization

1 reference

12 December 2020

Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain.

1 reference

12 December 2020

Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study

1 reference

12 December 2020

Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism

1 reference

12 December 2020

Selegiline in ADHD adults: plasma monoamines and monoamine metabolites.

1 reference

12 December 2020

A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

12 December 2020

Modulation of dopamine release by striatal 5-HT2C receptors

1 reference

12 December 2020

Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine

1 reference

12 December 2020

Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity

1 reference

12 December 2020

Behavioral and pharmacological studies on the validation of a new animal model for attention deficit hyperactivity disorder.

1 reference

12 December 2020

Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers

1 reference

12 December 2020

The acallosal mouse strain I/LnJ: a putative model of ADHD?

1 reference

12 December 2020

Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.

1 reference

12 December 2020

Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists

1 reference

12 December 2020

Development of monoamine systems after neonatal anoxia in rats.

1 reference

12 December 2020

Proposed animal model of attention deficit hyperactivity disorder.

1 reference

12 December 2020

Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.

1 reference

12 December 2020

Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction

1 reference

12 December 2020

The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals

1 reference

12 December 2020

Hyperactivity. Overview and new directions

1 reference

12 December 2020

Unilateral neonatal intracerebroventricular 6-hydroxydopamine administration in rats: II. Effects on extracellular monoamine, acetylcholine and adenosine levels monitored with in vivo microdialysis

1 reference

12 December 2020

Regulation by D2 dopamine receptors of in vivo dopamine synthesis in striata of rats and mice with experimental parkinsonism

1 reference

12 December 2020

Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospi

1 reference

12 December 2020

In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.

1 reference

12 December 2020

The effect of a 5-HT1A receptor agonist on striatal dopamine release

1 reference

12 December 2020

Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD).

1 reference

12 December 2020

Non-selective attention and nitric oxide in putative animal models of Attention-Deficit Hyperactivity Disorder.

1 reference

12 December 2020

Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions

1 reference

12 December 2020

Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.

1 reference

12 December 2020

Increase of central 5-HT1B binding sites following 5,7-dihydroxytryptamine axotomy in the adult rat

1 reference

12 December 2020

Dopamine neuronal transport kinetics and effects of amphetamine.

1 reference

12 December 2020

5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons

1 reference

12 December 2020

Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study

1 reference

12 December 2020

Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain.

1 reference

12 December 2020

Neonatal depletion of cortical dopamine: effects on dopamine turnover and motor behavior in juvenile and adult rats

1 reference

12 December 2020

The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants

1 reference

12 December 2020

The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens.

1 reference

12 December 2020

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1 reference

12 December 2020

Neurotoxic action of 6-hydroxydopamine on the nigrostriatal dopaminergic pathway in rats sensitized with D-amphetamine

1 reference

12 December 2020

Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine.

1 reference

12 December 2020

Lead-induced behavioral dysfunction: an animal model of hyperactivity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03033391

1 reference

9 February 2018

1 reference

9 February 2018